In October, Merck took up an option on the personalised RNA-based cancer vaccine with an upfront payment of $250 million as part of a collaboration first agreed in 2016 and expanded in 2018.

Merck & Co has said building its cardiovascular medicines business is central to its strategy to manage the loss of patent protection of cancer juggernaut Keytruda in five years, and new studies ...

CNET’s expert staff reviews and rates dozens of new products and services each month, building on more than a quarter century of expertise.

WATERAID UK, in collaboration with the Rural Water Supply and Sanitation Agency (RUWASA) in Manyara Region, has launched a pilot project in Hanang’ District to address water scarcity, inadequate ...

After hours: February 7 at 7:59:57 PM EST ...